Largest gift in university history names Cornell David A. Duffield College of Engineering

More than $520 million in contributions from David A. Duffield ’62, MBA ’64 – including a new pledge of $371.5 million and a 2025 commitment of $100 million, combined with previous gifts – will establish the Cornell David A. Duffield College of Engineering.

Designing the future: a Q&A with Harald Haraldsson

Through rapid prototyping and creative experimentation, Harald and his students explore how emerging technologies can reshape the way we interact with both digital and physical environments.

Around Cornell

Americans still see opioid overdose as a crisis

Approximately 88% of adults view opioid overdose deaths as a very serious problem with high agreement across political groups, according to a national survey conducted by Weill Cornell Medicine researchers.

Pre-cancerous states identified in seemingly normal aging tissues

A new single-cell profiling technique has mapped pre-malignant gene mutations and their effects in solid tissues for the first time, in a study led by investigators at Weill Cornell Medicine and the New York Genome Center.

Whole-genome sequencing may optimize PARP inhibitor use

The approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP inhibitor cancer treatments.

NYC residents agree: heat pumps improve comfort

Residents of a 10-unit apartment building retrofitted with electric heat pumps preferred the pumps to their oil-fueled boiler.

Pain-sensing neurons kick-start immune responses

Pain sensing neurons in the gut kindle inflammatory immune responses that cause allergies and asthma, according to a new study by Weill Cornell Medicine.

Urologist breaks the silence on women’s pelvic floor disorders

Though pelvic floor disorders happen when the muscles and tissues that support the bladder, bowel and uterus weaken or don’t work properly, and affect one-third of all women, they are not a normal part of aging.

Cornell-developed particles supercharge cancer immunotherapy

A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to rally the immune system against melanoma and dramatically improve the effectiveness of cancer immunotherapy.